Recital 14, Regulation (EU) 2026/977

In forcesince 4 May 2026

Timelines for product verification should be specific to class III or class IIb implantable devices and to class D in vitro diagnostic medical devices. Timelines should also apply in case of assessment of the technical documentation for a representative device on a sampling basis for other class IIb or IIa devices, as well as for class B and class C devices and for specific in vitro diagnostic medical devices, such as companion diagnostics, near-patient testing and self-testing devices.